Sweden· SE-20140521000029
Cerubidine 20 mg Pulver till infusionsvätska, lösning
A medicinal product containing daunorubicin, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Daunorubicin
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140521000029
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Daunorubicin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDaunorubicin 20mg powder for solution for infusion vialsA A H Pharmaceuticals Ltd
- BelgiumCerubidine 20 mgSanofi Belgium
- IrelandCerubidin 20 mg Powder for Concentrate for Solution for InfusionSanofi-Aventis Ireland Limited T/A SANOFI
- NorwayCerubidinSanofi-aventis Norge (3)
- United Statesdaunorubicin hydrochlorideMeitheal Pharmaceuticals Inc.
- FinlandCerubidinRhone-Poulenc Rorer A/S
- CanadaCERUBIDINESEARCHLIGHT PHARMA INC
- NetherlandsCerubidine 20mg, poeder en oplosmiddel voor oplossing voor injectieSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Daunoblastin
- Belgium · Cerubidine, Daunorubicine Hikma
- Germany · Daunoblastin
- Denmark · Daunorubicin ”hikma"
- Estonia · Daunoblastina
- Spain · Daunoblastina
- Finland · Daunorubicin Hikma
- France · Cerubidine, Daunorubicin Hikma
- United Kingdom (Northern Ireland) · Daunorubicin Zentiva Pharma Uk
- Croatia · Daunoblastina
- Hungary · Daunoblastina
- Ireland · Cerubidin
- Italy · Daunoblastina
- Luxembourg · Cerubidine
- Netherlands · Cerubidine, Daunorubicine Hikma
- Norway · Cerubidin, Daunorubicin Hikma
- Portugal · Daunorrubicina Hikma
- Slovakia · Daunoblastina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e93afd55-0133-4ca4-aaf4-4aaacf71f4d7 GET /v1/drugs/e93afd55-0133-4ca4-aaf4-4aaacf71f4d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20140521000029",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140521000029",
"product_doc_link": "https://docetp.mpa.se/LMF/Cerubidine%2020%20mg%20powder%20for%20solution%20for%20infusion%20BE%20PL_09001bee8080e9c2.pdf"
}See everything about daunorubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.